27 Sep 2021Ended

Sanofi's Journey & Strategy for Continuous Processing for Small Molecules


Estimated Turnout

upto 100
Based on previous editions


Sep 2021


Not Available
Claim event to edit details

In the past decade, there has been a growing interest in the application of continuous processing in the pharmaceutical industry with 100s millions .. Read more of investments and several products delivered to the market using this technology. Sanofi R&D is building capacities to perform future GMP clinical batches using this technology. The first investment was completed last year, and we are in the process of expansion. It is a really changing time for science at Sanofi. We are not only thinking machine; to enhance our ability to always produce best quality drugs to our patient, we are also implementing digital twin system, tracking and controlling the quality of our product at any moment of time. He started his career at Pfizer in 2003 as part of the process development team working on the development of the flow team. Since Flavien, worked for Novartis, GSK and more recently Sanofi.

  • Share your Experience
  • Organizer
Logo Follow Company


South Korea74 Total Events / 3 Upcoming Events

More Events From The Organizer